blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1294369

EP1294369 - NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.07.2006
Database last updated on 13.11.2024
Most recent event   Tooltip14.07.2006No opposition filed within time limitpublished on 16.08.2006  [2006/33]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2003/13]
Inventor(s)01 / Andersson, Mats J.
Medicarb AB Annedalsvägen 37
S-168 65 Bromma / SE
02 / Andersson, Mattias
AstraZeneca R & D Södertälje
S-151 85 Södertälje / SE
03 / Eriksson, Patrik
AstraZeneca R & D Södertälje
S-151 85 Södertälje / SE
 [2003/13]
Application number, filing date01934785.522.05.2001
[2003/13]
WO2001SE01164
Priority number, dateSE2000000191623.05.2000         Original published format: SE 0001916
[2003/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0189507
Date:29.11.2001
Language:EN
[2001/48]
Type: A1 Application with search report 
No.:EP1294369
Date:26.03.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 29.11.2001 takes the place of the publication of the European patent application.
[2003/13]
Type: B1 Patent specification 
No.:EP1294369
Date:07.09.2005
Language:EN
[2005/36]
Search report(s)International search report - published on:SE29.11.2001
ClassificationIPC:A61K31/15, A61K9/08
[2003/13]
CPC:
A61K9/08 (EP,US); A61K31/15 (EP,KR,US); A61K47/02 (EP,US);
A61K9/0019 (EP,US); A61P25/00 (EP); A61P25/28 (EP);
A61P39/06 (EP); A61P43/00 (EP); A61P9/00 (EP);
Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/13]
Extension statesAL23.12.2002
LT23.12.2002
LV23.12.2002
MK23.12.2002
RO23.12.2002
SI23.12.2002
TitleGerman:NEUE FORMULIERUNGEN VON -G(A)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRON[2003/13]
English:NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE[2003/13]
French:NOUVELLES FORMULATIONS DE $g(a)-2,4-DISULFOPHENYLE-N-TERT-BUTYLNITRONE[2003/13]
Entry into regional phase23.12.2002National basic fee paid 
23.12.2002Designation fee(s) paid 
23.12.2002Examination fee paid 
Examination procedure20.11.2001Request for preliminary examination filed
International Preliminary Examining Authority: SE
23.12.2002Examination requested  [2003/13]
14.10.2003Despatch of a communication from the examining division (Time limit: M06)
07.04.2004Reply to a communication from the examining division
28.05.2004Communication of intention to grant the patent
06.09.2004Fee for grant paid
06.09.2004Fee for publishing/printing paid
Opposition(s)08.06.2006No opposition filed within time limit [2006/33]
Fees paidRenewal fee
02.06.2003Renewal fee patent year 03
01.06.2004Renewal fee patent year 04
31.05.2005Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US5780510  (CARNEY JOHN M [US]);
 [A]US6107315  (CARNEY JOHN M [US], et al);
 [Y]  - MICHAEL E. AULTON, Pharmaceutics: The science of dosage form design, (1988), XP002948165 [Y] * page 368 - page 379 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.